After six weeks, the patients in each group slept about the same amount of time.

FORBES: Behavioral Therapy 1, Sleeping Pills 0

At 10 days the primary efficacy measure (a composite of asymptomatic proximal DVT, symptomatic DVT, symptomatic non-fatal PE, and VTE-related death) had occurred in 2.7% of patients in each group.

FORBES: Xarelto Effective In Medically Ill Patients But At High Bleeding Cost

There were 248 patients in the study, divided evenly between each group.

FORBES: Regeneron Announces Strong Results In Gout Study